CME at a glance
CME Group (CME, SEC CIK 1156375) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on July 24, 2026, an 8-K current report on September 25, 2026 and Form 4 insider filings as recently as September 28, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), CME Group (CME) reported revenue of $6.5 billion (up 6.4% from FY2024) and net income of $4.1 billion. Diluted EPS was $11.16.
- As of June 30, 2026, 57 institutional investment managers tracked by SignalX reported holding CME Group (CME) shares worth $32.4 billion in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by SHEPARD WILLIAM R on September 25, 2026 of 293 shares at $268.76 per share.
- In the last 90 days, CME insiders reported 1 open-market purchase ($79K) and 3 open-market sales ($4.3M) on Form 4, a net sale of $4.2M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $6.5B
- +6.4% vs prior year
- Insiders · 90 days
- 1 buy · 3 sells
- Net −$4.2M
- 13F holders
- 57 funds
- $32.4B · +3 vs prior quarter
- Latest 8-K
- Sep 25, 2026
- Item 5.03
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Global derivatives exchange operator: trading, clearing, and data services across interest rates, equities, FX, commodities, and crypto
- Two new 2025 platform launches: BrokerTec Chicago (second CLOB for cash U.S. Treasuries co-located with futures) and FX Spot+ (connects OTC spot FX with futures liquidity)
- CMESC received SEC approval in December 2025 to become a securities clearing agency, targeting U.S. Treasury (Dec 2026) and repo (June 2027) clearing mandates
- Record ADV of 28.1 million contracts in 2025; micro products +32% YoY, Asia Pacific trading hours volume +13% YoY
- Joint venture with FanDuel (Flutter Entertainment) launched December 2025: retail prediction markets app covering financial, economic, and sporting event contracts
Risk Factors
- FMX Futures Exchange and prediction market platforms (via FanDuel JV) directly targeting CME's derivatives and event-contract segments; litigation ongoing across multiple jurisdictions
- Basel III Endgame and potential GSIB capital surcharge changes could raise bank clearing firm capital requirements, reducing their trading activity in CME markets
- CyrusOne data center cooling failure (November 27, 2025) forced temporary market halt; single largest data center represents unhedged operational concentration
- $3.4B total debt outstanding as of December 31, 2025, with $2.3B additional borrowing capacity; fixed-cost structure amplifies earnings risk in low-volume environments
- 85% of 2025 derivatives contract volume from members holding board seats and conflicting economic interests vs. Class A shareholders
Management Discussion & Analysis
- Revenue $6,520.6M in 2025, up ~6.4% YoY from $6,130.1M; clearing & transaction fees $5,281.1M (+5.9%), market data $803.1M (+13.1%)
- Operating margin 64.9% vs 64.1% in 2024; net income $4,072.2M vs $3,525.8M; diluted EPS $11.16 vs $9.67
- Best segment: market data +$92.9M YoY; contract volume up 5.6% to 7,060.4M driven by interest rates (+3.6%) and equity indexes (+8.2%); FX weakest, volume down ~5%
- Operating cash flow $4,277.1M vs $3,690.5M; capex guided ~$85M for 2026; $2.7B remaining under $3.0B buyback authorization; variable dividend $6.15/share plus quarterly $1.30/share declared Feb 2026
- Key risks: tariff uncertainty, Fed rate policy, competitive intensity; OSTTRA JV sold in Q4 2025 generating $306.1M gain; Google Cloud transformation ongoing with shifting cost profile
AI summary of the CME 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Revenue $1,706.2M, up 1% YoY; market data strongest at $238.1M, up 20%
- Operating margin 64.9% vs 66.7% YoY; net income $1,041.8M, up 2%
- Equity indexes best volume performer, up 13%; energy worst, down 13%
- Operating cash flow $2,207.0M; financing cash use higher from increased share repurchases
- Q2 volatility subsided; lower interest-rate and energy volumes amid greater policy certainty and regional stabilization
Risk Factors
- No material changes to risk factors from December 31, 2025 Form 10-K
- Market risk: trading volumes and fee revenue remain sensitive to volatility and economic conditions
- Regulatory risk: extensive derivatives regulation may increase compliance costs and constrain operations
- Operational risk: exchange, clearing, and technology disruptions could impair transaction processing
- Financial risk: clearinghouse exposures and member defaults could create liquidity demands
AI summary of the CME 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 5.03: Amendments to Articles of Incorporation or Bylaws
- Series G Non-Voting Convertible Preferred Stock designation eliminated effective September 24, 2026
- No Series G shares outstanding, limiting direct shareholder impact
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Jack Tobin named Deputy CFO November 2, 2026, then CFO in March 2027
- Planned retirement deferred, preserving finance leadership continuity through succession
Item EX-99.1: Item EX-99.1
- Jack Tobin becomes CFO in March 2027, succeeding Lynne Fitzpatrick as she becomes CEO
- Tobin becomes Deputy CFO in November 2026, supporting an extended finance leadership transition
Item 7.01: Regulation FD Disclosure
- CME communicated client pricing changes through Special Executive Report No. 9799 on August 11, 2026
- Pricing changes may affect customer transaction economics and CME revenue expectations
AI summaries of CME 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for CME
Don't miss the next CME filing
- Alerts as it files. A push when CME files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut CME, by share count.
- Ask anything. An AI agent that reads every CME filing and answers with sources.
CME alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| SHEPARD WILLIAM R | Buy | Sep 25, 2026 | 292.55 | $268.76 |
| Sammann Derek | F | Sep 16, 2026 | 359 | $272.46 |
| Fitzpatrick Lynne | F | Sep 16, 2026 | 359 | $272.46 |
| Dennis Michael G. | F | Sep 16, 2026 | 274 | $272.46 |
| Marchese John Clifford | F | Sep 16, 2026 | 44 | $272.46 |
| Tobin Jack J | F | Sep 16, 2026 | 51 | $272.46 |
| Sprague Suzanne | F | Sep 16, 2026 | 308 | $272.46 |
| McCourt Timothy Francis | F | Sep 16, 2026 | 364 | $272.46 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $6.1B | $6.5B |
| Operating Income | $3.4B | $3.9B | $4.2B |
| Net Income | $3.2B | $3.5B | $4.1B |
| Op. Margin | - | 64.1% | 64.9% |
| Net Margin | - | 57.5% | 62.5% |
| Balance Sheet | |||
| Total Assets | - | $137.4B | $198.4B |
| Equity | - | $26.5B | $28.7B |
| ROE | - | 13.3% | 14.2% |
| Per Share | |||
| EPS | - | $9.67 | $11.16 |
| Cash Flow | |||
| Operating CF | $3.5B | $3.7B | $4.3B |
| CapEx | $76.4M | $94.0M | $83.5M |
Source: XBRL data in CME Group (CME)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate CME share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 57 | $32.38B |
| Q1 2026 | 54 | $45.16B |
| Q4 2025 | 50 | $40.63B |
| Q3 2025 | 53 | $43.65B |
| Q2 2025 | 50 | $42.60B |
| Q1 2025 | 46 | $31.01B |
| Q4 2024 | 44 | $20.70B |
| Q3 2024 | 39 | $11.21B |
- Two Sigma Investments+1.27M (+110%)
- D.E. Shaw & Co+1.19M (+860%)
- Citadel Advisors LLC+1.13M (+303%)
- Millennium Management+1.03M (+612%)
- Invesco Ltd+908.8K (+42%)
- JPMorgan Chase & Co−6.44M (-53%)
- T. Rowe Price Group−2.72M (-57%)
- FMR LLC (Fidelity)−2.44M (-65%)
- Bank of America Corp−1.20M (-30%)
- BNY Mellon−905.1K (-19%)
- Baupost Group+619.0K
- Viking Global Investors+153.0K
- StoneX Group Inc.+1.7K
- Blackstone Group+1.1K
- OLD NATIONAL BANCORP /IN/+1.1K
Source: 13F-HR filings on SEC EDGAR (aggregated from 393 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
CME filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Sep 28, 2026 | - | - | - |
| 8-K | Sep 25, 2026 | - | Analysis | - |
| 4 | Sep 17, 2026 | - | - | - |
| 4 | Sep 17, 2026 | - | - | - |
| 4 | Sep 17, 2026 | - | - | - |
| 4 | Sep 17, 2026 | - | - | - |
| 4 | Sep 17, 2026 | - | - | - |
| 4 | Sep 17, 2026 | - | - | - |
| 4 | Sep 17, 2026 | - | - | - |
| 4 | Sep 17, 2026 | - | - | - |
| 4 | Sep 17, 2026 | - | - | - |
| 4 | Sep 17, 2026 | - | - | - |
| 4 | Sep 17, 2026 | - | - | - |
| 4 | Sep 14, 2026 | - | - | - |
| 4 | Sep 11, 2026 | - | - | - |
| 8-K | Sep 9, 2026 | - | Analysis | - |
| 8-K | Aug 11, 2026 | - | Analysis | - |
| 10-Q | Jul 24, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 22, 2026 | - | Analysis | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 29, 2026 | - | - | - |
Related Financials companies
- BGC · BGC Group, Inc.Security & Commodity Brokers, Dealers, Exchanges & Services
- CBOE · Cboe Global MarketsSecurity & Commodity Brokers, Dealers, Exchanges & Services
- ICE · Intercontinental ExchangeSecurity & Commodity Brokers, Dealers, Exchanges & Services
- MRX · Marex Group plcSecurity & Commodity Brokers, Dealers, Exchanges & Services
- NDAQ · Nasdaq, Inc.Security & Commodity Brokers, Dealers, Exchanges & Services
- SNEX · StoneX Group Inc.Security & Commodity Brokers, Dealers, Exchanges & Services
- TW · Tradeweb Markets IncSecurity & Commodity Brokers, Dealers, Exchanges & Services
- SRCE · 1ST SOURCE CORPState Commercial Banks
CME SEC filings: frequently asked questions
Are CME insiders buying or selling?
In the last 90 days, CME Group (CME) officers, directors and 10% owners reported 1 open-market purchase worth $78,626 by 1 insider and 3 open-market sales worth $4.3 million by 2 insiders on Form 4, a net sale of $4.2 million. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold CME stock?
As of June 30, 2026, the largest CME Group (CME) holders among the 13F filers tracked by SignalX were BlackRock ($6.7 billion), Vanguard Capital Management LLC ($5.2 billion), State Street Corp ($3.6 billion), Morgan Stanley ($2.1 billion), Vanguard Portfolio Management LLC ($2.0 billion). 13F-HR reports are filed up to 45 days after each quarter ends.
What was CME's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), CME Group (CME) reported revenue of $6.5 billion (up 6.4% from FY2024) and net income of $4.1 billion. Diluted EPS was $11.16. The figures come from the XBRL data in the 10-K.
What are the main risks in CME's latest 10-K?
In the 10-K filed February 26, 2026, CME Group (CME) flagged: FMX Futures Exchange and prediction market platforms (via FanDuel JV) directly targeting CME's derivatives and event-contract segments; litigation ongoing across multiple jurisdictions. Basel III Endgame and potential GSIB capital surcharge changes could raise bank clearing firm capital requirements, reducing their trading activity in CME markets. (AI summary of the Risk Factors section.)
What did CME report in its latest 8-K?
CME Group (CME) filed an 8-K on September 25, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws). Series G Non-Voting Convertible Preferred Stock designation eliminated effective September 24, 2026.
What are the latest CME SEC filings?
CME Group (CME) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on July 24, 2026, an 8-K current report on September 25, 2026 and a Form 4 insider filing on September 28, 2026.
What is CME's SEC CIK number?
CME Group (CME)'s SEC Central Index Key (CIK) is 1156375. EDGAR lists every CME filing under that number.
Ask anything about CME
The research agent reads CME's filings, financials, insider trades and 13F holders, then answers with sources.